The anti-SARS-CoV-2 vaccination is recommended for pregnant women due to the high risk
of complications. However, pregnancy has been associated with vaccine hesitancy. Our …

Influenza, tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap), and
COVID-19 vaccines can reduce the risk for influenza, pertussis, and COVID-19 among …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy is
associated with significant maternal morbidity and mortality, and its risks can be mitigated …

Pregnant people with COVID-19 are at increased risk of severe illness and death compared
with non-pregnant females of reproductive age (aged 15–49 years). 1 Additionally, COVID …

National estimates suggest that COVID-19 vaccination coverage among pregnant persons is
lower among those identifying as Hispanic or Latino (Hispanic) and non-Hispanic Black or …

Pregnant persons are at higher risk of severe COVID-19. Although vaccination is
recommended, COVID-19 vaccination rates are lower among pregnant persons compared …

Immunization strategies are part of routine pregnancy care to prevent infectious diseases in
the mother, the fetus, and the newborn. Maternal immunization recommendations followed …

Abstract The US Centers for Disease Control and Prevention (CDC) developed and
implemented the CDC COVID-19 Vaccine Pregnancy Registry (C19VPR) to monitor vaccine …

Background Pregnant women and their fetuses are particularly susceptible to respiratory
pathogens. How they respond to SARS-CoV-2 infection is still under investigation. Methods …

To date, extensive research has been conducted on vaccination against COVID-19 during
pregnancy to verify the safety and efficacy of the vaccines, despite the fact that pregnant …